Cystic Fibrosis Screening - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

Cystic Fibrosis Screening

Description:

Gene called CFTR (cystic fibrosis transmembrane conductance regulator) ... Edenborough FP (2001) Women with cystic fibrosis and their potential for reproduction. ... – PowerPoint PPT presentation

Number of Views:119
Avg rating:3.0/5.0
Slides: 32
Provided by: robertre
Category:

less

Transcript and Presenter's Notes

Title: Cystic Fibrosis Screening


1
Cystic Fibrosis Screening
  • Robert Resta, M.S., C.G.C
  • Director of Genetic Counseling Services
  • Division of Perinatal Medicine
  • Swedish Medical Center
  • Feel free to use these materials in your own
    educational practices. The two graphics on
    slides 10 11 are for noncommercial purposes
    only. Except as provided by law, this material
    may not be further reproduced, distributed,
    transmitted, modified, adapted, performed,
    displayed, published, or sold in whole or in
    part, without prior written permission from the
    publisher.

2
ACOG/ACMG Guidelines For CF Screening
  • Individuals with a family hx of CF
  • Reproductive partners of CF patients
  • Caucasian couples who are pregnant or planning a
    pregnancy
  • Make screening available to other ethnic
    groups if pregnant/planning pregnancy

3
CF Symptoms
  • Chronic sino-pulmonary disease
  • Gastrointestinal/nutritional problems
  • Salt-loss syndromes
  • Normal intellect
  • Life span about 30 years
  • If pancreatic sufficient, life span 56 years

4
CF Symptoms
  • Severity is extremely variable
  • Males have obstructive azoospermia
  • Females have reduced fertility
  • Pregnant females at ? risk FOR OB complications,
    especially if pulmonary insufficient

5
CF Treatment
  • Antibiotics
  • Mucolytics
  • Chest physiotherapy
  • Enzyme/vitamin supplementation
  • Heart/Lung transplant
  • Gene therapy still experimental

6
CF Genetics
  • Autosomal recessive, i.e., both parents must be
    carriers
  • If carriers, 1/4 (25) risk of affected child,
    with each pregnancy, regardless of sex of child
  • Carriers usually asymptomatic
  • Usually no family history of CF

7
CF Genetics
  • Most common genetic disease in N/W Europeans
  • Carrier Frequency in N/W Europeans 1/28
  • Disease Incidence in N/W Europeans 1/3300
    births
  • Carrier and disease frequency much lower in
    other populations

8
CF Genetics
9
CF Genetics
  • CF gene identified in 1989
  • Maps to long arm of chromosome 7
  • Gene called CFTR (cystic fibrosis transmembrane
    conductance regulator)
  • Membrane protein, epithelial chloride channel

10
Location of CF Gene on Chromosome 7
Reprinted with permission from Schuler et al.,
Science 274, 540 (1996). American Association for
the Advancement of Science
11
CFTR Is A Membrane Protein
IMAGE CREDIT Q. Alawqati, Columbia University,
NY, USA. Adapted by K. Sutliff, SCIENCE
12
CF Genetics
  • More than 900 mutations in the CFTR gene
  • Mutations result in reduced synthesis, blocked
    protein processing, blocked regulation of
    chloride channel, or altered conductance of
    chloride channel

13
Common Mutations(adapted from ACOG, 2001)
14
CF Genetics
  • Mutations in other populations not well
    characterized
  • Mutations do not always predict severity of
    disease

15
CF Carrier Screening
  • DNA test
  • Not affected by pregnancy
  • Works equally well in both sexes
  • Should be done prior to, or very early in,
    pregnancy

16
CF Carrier Screening
  • 5-10 ccs whole blood
  • Purple or yellow top tube
  • No special handling required
  • Room temperature okay
  • Very important to identify ethnicity to lab

17
CF Carrier Screening
  • Test available through most major labs
  • Cost 225-350 per patient
  • Test patient OR partner
  • If one negative, no need to test other

18
CF Carrier Screening
  • ACOG/ACMG recommend screening for 25 most common
    mutations
  • This should detect 90 of N/W European carriers
    and 95 of Ashkenazi carriers
  • Carrier detection rate in other populations much
    lower

19
CF Carrier Screening
Adapted from ACOG (2001)
20
CF Carrier Screening
  • A normal result means a lower chance of being a
    carrier and of having an affected child.
  • Screening does not detect all carriers!!

21
CF Carrier Screening
Adapted from ACOG (2002)
22
CF Carrier Screening
  • False positives are rare
  • Fetus at risk if the patient and partner carry
    different mutations (
    i.e., compound heterozygote)

23
CF Management of Results
  • If patient negative, go no further
  • If positive, refer for genetic counseling
  • If positive, test partner
  • If partner negative, go no further

24
(No Transcript)
25
CF Management of Results
  • If patient and partner positive, 1/4 chance of
    affected child
  • Amniocentesis or CVS
  • If patient OR partner positive, other relatives
    should be notified

26
CF Male Infertility
  • 80 of males with CBAVD are CF carriers or
    homozygotes
  • 5T allele normally benign unless occurs with
    other CF mutation
  • 30 of males with CUAVD are CF carriers
  • Refer these men for genetic counseling

27
CF High Risk Patients
  • Males with bilateral/unilateral absence of vas
    deferens
  • Patient or partner with family history of CF
  • Fetus with echogenic bowel
  • Refer all of above for genetic counseling

28
References
  • American College of Obstetricians and
    Gynecologists, American College of Medical
    Genetics (2001) Preconception and prenatal
    carrier screening for cystic fibrosis. ACOG
    Washington, DC.
  • Chillon M et al (1995) Mutations in the cystic
    fibrosis gene in patients with congenital absence
    of the vas deferens. NEJM 3321475-1480.
  • Doull IJ (2001) Recent advances in cystic
    fibrosis. Arch Dis Child 85(1)62-66.
  • Edenborough FP (2001) Women with cystic fibrosis
    and their potential for reproduction. Thorax
    56(8)649-655.
  • Flotte R, Laube BL (2001) Gene therapy in cystic
    fibrosis. Chest 120(3)124S-131S.

29
References (2)
  • Le Maréchal C, Audrézet MP, Quéré I, Raguénès O,
    Langonné S, Férec C (2001) Complete and rapid
    scanning of the cystic fibrosis transmembrane
    conductance regulator (CFTR) gene by denaturing
    high-performance liquid chromatography (D-HLPC)
    major implications for genetic counselling. Hum
    Genet 108290-298.
  • Noone, PG, Knowles MR (2001) CFTR-opathies
    disease phenotypes associated with cystic
    fibrosis transmembrane regulator gene mutations.
    Respir Res 2328-332.
  • Orenstein DM, Winnie GB, Altman H (2002) Cystic
    fibrosis A 2002 Update. J Pediatr 140156-164.
  • Robinson P (2001) Cystic fibrosis. Thorax 56(3)
    237-241.

30
Helpful Web Sites
  • GeneReviews http//www.geneclinics.org
  • CF Mutation Site - http//www.genet.sickkids.on.ca
    /
  • General Information for Public and Physicians -
    http//www.cysticfibrosis.co.uk
  • Cystic Fibrosis Foundation - http//www.cff.org/

31
  • You have completed the online CME. Now close
    this window to return to the web site to take the
    quiz. Print out the quiz, answer the questions,
    and mail it to us for credit.
Write a Comment
User Comments (0)
About PowerShow.com